ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share (AVBP)

Q: What does CUSIP 04272N102 represent in this 13F holders report?

CUSIP 04272N102 is the security identifier for AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share used to aggregate holder disclosures.

Q: How many institutions held AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share in Q3 2024?

68 institutional investors reported AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 04272N102

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Common Stock, $0.0001 Par Value per Share
Total 13F shares: 25,909,614
Total 13F value: $612,333,484
Share change: +2,981,984
SEC-reported price per share: $23.50
Number of holders: 68
Value change: +$70,385,573
Number of buys: 50
Number of sells: 5
Shares outstanding: 49,454,020

Security key

04272N102

Report period

Q3 2024

Institutions

Top holders

AVBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 ArriVent BioPharma, Inc. SEC filings ArriVent BioPharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 04272N102

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 Par Value per Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

HHLR ADVISORS, LTD.

Comparable rows

0/15

Latest evidence

30 Jun 2024

13F 3/4/5 Highest disclosed value: $83,190,666 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

HHLR ADVISORS, LTD. has the largest disclosed position value at $83.19M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HHLR ADVISORS, LTD.'s linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $56.16M

Carl L. Gordon $5.52M

HHLR ADVISORS, LTD. $83.19M

FMR LLC $36.18M

Octagon Capital Advisors LP $33.45M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F 3/4/5 Company · Director, 10%+ Owner 13F 3/4/5	— denominator unverified	$56,156,934 3,027,328 shares	—	30 Jun 2024
Carl L. Gordon	3/4/5 Director, 10%+ Owner 3/4/5	— denominator unverified	$5,524,874 1,513,664 shares	—	30 Jan 2024
HHLR ADVISORS, LTD.	13F Company 13F	— denominator unverified	$83,190,666 4,484,672 shares	—	30 Jun 2024
FMR LLC	13F Company 13F	— denominator unverified	$36,175,858 1,950,181 shares	—	30 Jun 2024
Octagon Capital Advisors LP	13F Company 13F	— denominator unverified	$33,451,289 1,803,304 shares	—	30 Jun 2024
MONTANOVA CAPITAL, LLC	13F Company 13F	— denominator unverified	$31,770,641 1,712,703 shares	—	30 Jun 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

25,909,614

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend